Epitopea
PrivateLast Round
Pre Seed
Oct 24, 2024
Total Funding Raised
$45.26M
Momentum Score
75 /100
Company Overview
Epitopea is a biotechnology company specializing in the development of transatlantic cancer immunotherapeutics that target a novel class of tumor-specific antigens to effectively eliminate malignant cells while minimizing side effects.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epitopea Comps
Public and private peers based on sector, stage, and business model.
Epitopea Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 24, 2024 | ||||
| Grant | Sep 12, 2024 | ||||
| Seed | Apr 25, 2022 |
Epitopea Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Investissement Québec | Pre Seed |
| Fonds de solidarité FTQ | Pre Seed, Seed |
| Advent Life Sciences | Pre Seed, Seed |
| Novateur Ventures | Pre Seed, Seed |
| Cambridge Innovation Capital | Pre Seed, Seed |
| adMare BioInnovations | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Susana Banerjee appointed Chief Investigator for OVACT trial.
- Apr 13, 2026
Lisa Butterfield appointed to the Scientific Advisory Board.
Epitopea Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Epitopea's valuation, stock price, and market status.
